To amend the Federal Food, Drug, and Cosmetic Act to enhance medical device communications and ensure device cleanliness.
Summary
What This Bill Does
The bill requires reporting requirement for design and reprocessing instruction changes Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, requires reporting requirement for certain communications to foreign health care providers Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and requires rapid assessment tests intended to ensure proper reprocessing Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. It relies on definition changes, reporting requirements, and compliance mandates. The main policy areas are Healthcare Consumers, Healthcare, Technology, and Finance.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Telecommunications providers and users affected by the bill would take on compliance duties, and Patients and health care consumers affected by the bill would take on compliance duties.
Key Provisions
- Requires reporting requirement for design and reprocessing instruction changes Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
- Requires reporting requirement for certain communications to foreign health care providers Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
- Requires rapid assessment tests intended to ensure proper reprocessing Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires reporting requirement for design and reprocessing instruction changes Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, requires reporting requirement for certain communications to foreign health care providers Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and requires rapid assessment tests intended to ensure proper reprocessing Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Key Policy Areas
Healthcare Consumers, Healthcare, Technology, Finance
Primary Purpose
The bill requires reporting requirement for design and reprocessing instruction changes Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, requires reporting requirement for certain communications to foreign health care providers Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and requires rapid assessment tests intended to ensure proper reprocessing Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Telecommunications providers and users affected by the bill
- Patients and health care consumers affected by the bill
- Businesses and employers affected by the bill
- Foreign businesses and cross-border trade participants affected by the bill
Sponsors
Legislative Progress
IntroducedMr. Lieu (for himself, Ms. Chu, and Ms. Norton) introduced …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology